Menu Fermer

Articles sur Pharmaceuticals

Affichage de 1 à 20 de 172 articles

Generic drug names are assigned at the global level by the World Health Organization in conjunction with national naming authorities. (Shutterstock)

Generic drug names provide information for doctors, so why is Health Canada promoting the use of pharma brand names?

Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Until the late 19th century, patenting medicines was considered by some as controversial and even unethical. S. Vannini/De Agostini Editorial

The US drug industry used to oppose patents – what changed?

The pharmaceutical industry overall has been deeply opposed to waiving COVID-19 vaccine patents, but a historian of the industry explains that drug companies once opposed patents altogether.
Though drug recalls are relatively uncommon in the U.S., reduced inspections increase the likelihood of manufacturing errors that slip through the cracks. AP Photo/Rafiq Maqbool

The FDA’s weak drug manufacturing oversight is a potentially deadly problem

COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
Pharmaceutical companies recalled metformin, a Type 2 diabetes drug, after finding high levels of NDMA impurities. Scott Olson via Getty Images

Zantac unlikely to turn into cancer-causing chemical in the body, but concerns remain about how drugs age on the shelf

The FDA recalled commonly used heartburn and ulcer medication ranitidine in April 2020. But new research suggests less reason for alarm.
Despite monitoring the same drugs, Australia, Canada, the United Kingdom and the United States issued the same drug warnings only seven per cent of the time over a 10-year period. (Pixabay)

Drug Safety: Health Canada must act faster when approved medications show risks

Health Canada devotes far more resources to getting new drugs onto the market compared to making sure that drugs already being sold are safe.

Les contributeurs les plus fréquents

Plus